Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Dasatrue 70 mg Tablet
Manufacturer/Marketed By : Cipla Ltd
$96.33 $70.74
Dasatrue 70 mg Tablet is a potent medication that plays a crucial role in the fight against cancer, specifically targeting chronic myeloid leukemia (CML), a malignancy characterized by the overproduction...
Dasatinib 70 mg
Active Pharmaceutical Ingredient
Dasatrue 70 mg Tablet
$96.33
$70.74
Dasatrue 70 mg Tablet is a potent medication that plays a crucial role in the fight against cancer, specifically targeting chronic myeloid leukemia (CML), a malignancy characterized by the overproduction of white blood cells. The active ingredient, dasatinib, belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific proteins that promote cancer cell growth and division, ultimately leading to reduced tumor progression. Patients taking Dasatrue should be aware of potential side effects, including low blood cell counts, which may increase the risk of infections or bleeding, and should monitor for symptoms such as unusual bruising or fatigue. It is essential to follow your healthcare provider's instructions regarding dosage and administration to maximize the therapeutic benefits while minimizing risks. Regular blood tests are often necessary to assess your body’s response to the treatment and to manage any side effects effectively. Always consult with your doctor before starting or stopping any medication, and inform them of any other treatments you are undergoing to avoid harmful interactions. Dasatrue 70 mg Tablet represents a significant advancement in oncology, offering hope to patients battling CML and improving their quality of life.
Active Pharmaceutical Ingredient
Uses
• Dasatrue 70 mg tablet is primarily indicated for the treatment of chronic myeloid leukemia (CML). This condition affects the blood and bone marrow, leading to an overproduction of abnormal white blood cells. Patients may experience symptoms such as fatigue, weakness, and an enlarged spleen. By targeting the underlying causes of CML, Dasatrue 70 mg tablet helps manage the disease effectively.
• In addition to CML, Dasatrue 70 mg tablet is also used for acute lymphoblastic leukemia (ALL). This aggressive form of leukemia arises from the bone marrow and results in the rapid proliferation of immature white blood cells. Patients suffering from ALL may present with symptoms like easy bruising, shortness of breath, and frequent infections. The administration of Dasatrue 70 mg tablet plays a crucial role in controlling the progression of this fast-growing cancer.
• Dasatrue 70 mg tablet is beneficial in managing specific leukemia-related symptoms and complications. For instance, it can help reduce fatigue and improve overall quality of life for individuals diagnosed with CML or ALL. By effectively targeting the cancer cells, Dasatrue 70 mg tablet aids in alleviating some of the debilitating effects of these conditions. This can lead to better treatment outcomes and improved patient well-being.
• Healthcare providers may prescribe Dasatrue 70 mg tablet as part of a comprehensive treatment plan for leukemia patients. It is essential in combination with other therapies to enhance the overall effectiveness of cancer treatment. Regular monitoring and assessments are crucial while using Dasatrue 70 mg tablet to ensure optimal results. This collaborative approach helps in tailoring treatment strategies to meet individual patient needs.
Benefits
Dasatrue 70 mg Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Dasatrue Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Anti-cancer Drug Dasatrue is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Dasatrue 70 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Vomiting
• Bleeding
• Skin rash
• Diarrhoea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Dasatrue 70 mg Strip may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Dasatinib Tablet 70 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Dasatinib Tablet 70 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Anti-cancer Drug Dasatrue should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Dasatrue 70 mg. Dasatrue 70 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Dasatinib Tablet 70 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dasatinib Tablet 70 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Dasatrue 70 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dasatrue 70 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dasatrue Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dasatrue 70 mg Strip during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dasatrue 70 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Dasatrue 70 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.